| Breast Cancer |
1 |
1 |
| HER2-Positive Breast Cancer |
0 |
0.92 |
| Advanced and Metastatic Breast Cancer |
0 |
0.73 |
| Breast Cancer History |
0 |
0.71 |
| Biologic Therapy |
0 |
0.65 |
| Cancer |
0 |
0.65 |
| Antineoplastic Drug |
0 |
0.62 |
| Breast |
0 |
0.55 |
| Chemotherapy |
0 |
0.26 |
| Adjuvant Chemotherapy |
0 |
0.21 |
| Europe |
0 |
0.16 |
| Humanized Monoclonal Antibody |
0 |
0.16 |
| Prognosis |
0 |
0.13 |
| Patient Safety |
0 |
0.12 |
| Adverse Effects |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Board Certification |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Medical Oncology |
0 |
0.07 |